Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-Year Antiviral Efficacy of Nevirapine and Efavirenz in 2NN and CHARM Patients
NCT00127972Phase 4Completed
- Sponsor
- International Antiviral Therapy Evaluation Center
- Start
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nevirapine in human immunodeficiency virus infection (HIV) (6 arms), sponsored by International Antiviral Therapy Evaluation Center. Primary endpoint: Number of patients with treatment failure at 144 weeks. Started Feb 2004; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00127972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127972.